Skip directly to site content
Skip directly to search
Español
|
Other Languages
Genomics & Precision Health
Part IV: CASE STUDIES: Using Human Genome Epidemiology Information to Improve Health Chapter 24 Figures
Print
Minus
Related Pages
Figure 24-1
Population-specific epidemiological data processing to GJB2 and nonsyndromic hearing loss. Contribution of GJB2 variants (35ΔG, 167ΔT, and 235ΔC) to nonsyndromic hearing loss in
United States
(White Americans) (37,55,57,59,66)
Europe (29-32)
Tunisia (42)
Israel (23,24)
Korea (33)
Japan (34-36)
Australia (60)
No variation
67%
59
82
50%
87
79
76%
35ΔG/35ΔG
16%
18
16
12
4
35ΔG/other
5%
5
4
35ΔG/unknown or 35ΔG/+
9%
16
2
6
2
6
35ΔG/167ΔT
0%
10
167ΔT/167ΔT or 167ΔT/other
2
1
18
167ΔT/+
0
2
235ΔC/235ΔC
0
4
8
235ΔC/other
0
4
8
2
235ΔC/+
0
1
2
Other/other
1
2
2
3
3
Other/+
0
1
5
[back to chapter]
Last Reviewed:
January 1, 2004
Source:
National Center on Birth Defects and Developmental Disabilities
,
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
home
Genomics & Precision Health
About Us
Reports and Publications
Genomics and Precision Health Blog
Events, Training and Multimedia
Genetics 101
Family Health History
Genetic Counseling and Testing
plus icon
Genetic Counseling
Genetic Testing
Evaluating Genomic Tests
Genomics and Precision Health Topics
plus icon
Breast and Ovarian Cancer
Cascade Testing
Colorectal Cancer
Cystic Fibrosis
Diabetes
Heart Disease
Hereditary Hemochromatosis
Hypertrophic Cardiomyopathy
Obesity
Osteoporosis
Pharmacogenomics
Polygenic Risk Score
Precision Medicine
Real Stories
My Family Health History Portrait
More Resources
plus icon
Epidemiology
Implementation
Pathogen Genomics